| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/15/2004 | CN1528887A Tumour targeting bigene-virus structure method |
| 09/15/2004 | CN1528884A Chicken escherichia coli heterotype outer membrane protein cell engineered bacterial strain preparing method |
| 09/15/2004 | CN1528880A Apparatus for immobilized DNA library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes system atically |
| 09/15/2004 | CN1528791A Specific monoclonal antibody against epitope of clygoprotein coding inactivated feline immunodeficiency virus |
| 09/15/2004 | CN1528784A Epidermal staphylococcus regulatory signal polypetide and coding DNA |
| 09/15/2004 | CN1528452A Method for preparing broad spectrum genetically engineered nano vaccine for malignant tumour |
| 09/15/2004 | CN1166947C Apparatus and method for taget analyte of nucleotide series in sample |
| 09/15/2004 | CN1166784C Process for labeling ribonucleic acid and labeled RNA fragments obtained thereby |
| 09/15/2004 | CN1166779C High-temp. resistant isocitric dehydrogenase gene, its coded polypeptide and its preparation method |
| 09/15/2004 | CN1166778C DNA fragments containing biotin biosynthesizing gene and use of same |
| 09/15/2004 | CN1166777C Human Sel-10 polypeptides and polynucleotides that encode them |
| 09/15/2004 | CN1166776C Use of human vascular IBP-like growth factor for preparing reagent for diagnosis of blood vascular disease etc. |
| 09/15/2004 | CN1166775C Application of transgene paddy rice endosperm in genetics demonstration experiment |
| 09/15/2004 | CN1166774C Method for reconstructing a non-human mammal embryo with foetal adult differentiated cells |
| 09/15/2004 | CN1166772C Process for controlling sialylation of protein produced by mammalian cell culture |
| 09/15/2004 | CN1166770C Overproduction of riboflavin in yeast |
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166686C New human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 09/15/2004 | CN1166681C Preparation of purified (poly) peptides |
| 09/15/2004 | CN1166410C Nucleic acid transporters and medicinal compositions for gene therapy |
| 09/14/2004 | US6792356 Apparatus and method for automated protein design |
| 09/14/2004 | US6791015 Fructan biosynthetic enzymes |
| 09/14/2004 | US6791014 Use of HPPD inhibitors as selection agents in plant transformation |
| 09/14/2004 | US6791013 Nucleotide sequences coding regulatory sequences; for use in generating genetically engineered plant |
| 09/14/2004 | US6791012 Salt-tolerant transgenic turfgrass |
| 09/14/2004 | US6791011 For producing male-sterile plants and hybrid seeds; cell ablation |
| 09/14/2004 | US6791010 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications |
| 09/14/2004 | US6791009 Comprises antisense gene of entamoeba calcium binding protein; nopaline synthase (nos) polyadenylation signal sequence |
| 09/14/2004 | US6791008 Use of a gene encoding an enzyme with acyl-coa:diacylglycerol acyltransferase activity |
| 09/14/2004 | US6791007 Polynucleotide and its use for modulating a defence response in plants |
| 09/14/2004 | US6791006 LKB1 gene knockout mice |
| 09/14/2004 | US6790951 Expression system in microorganism and its use for expressing heterologous and homologous proteins |
| 09/14/2004 | US6790950 Anti-bacterial vaccine compositions |
| 09/14/2004 | US6790949 Used in the development of a therapeutic agent for neuron or endocrine cell-related diseases; vesicle transport proteins |
| 09/14/2004 | US6790945 Fluorescent quenching detection reagents and methods |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790940 For high speed detection |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790936 Carboxyamido-triazole (cai); sh domains; for use in cancer therapy; drug screening |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790658 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer |
| 09/14/2004 | US6790657 For use in gene transfer; improving encapsidation of transgene rna with retroviral packaging |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790651 Hybridization reaction apparatus and hybridization method |
| 09/14/2004 | US6790650 Cacao endoproteinases and production of cocoa flavor from same |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790648 DNA fragmentation factor involved in apoptosis |
| 09/14/2004 | US6790647 Genetically engineered, feed back desensitized lyase for biosynthesis of arginine from glutamate in escherichia |
| 09/14/2004 | US6790646 Amine oxidase for use in the treatment of nervous system disorders |
| 09/14/2004 | US6790642 Method for reducing the amount of nucleic acid adhering to a hydrophobic surface |
| 09/14/2004 | US6790641 Lentiviral vector particles resistant to complement inactivation |
| 09/14/2004 | US6790640 Method of increasing conversion of a fatty acid to its corresponding dicarboxylic acid |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790637 Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes |
| 09/14/2004 | US6790633 Prevents binding of ras protein in malignant cells |
| 09/14/2004 | US6790631 For diagnosis and therapy of prostate cancer; qualitative analysis |
| 09/14/2004 | US6790630 Glycoproteins; pepsin inhibitors; for detection of heartworm infection in dogs, cats |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790624 Coiled-coil mediated heterodimerization functional interaction trap |
| 09/14/2004 | US6790623 DNA detection by means of a strand reassociation complex |
| 09/14/2004 | US6790622 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 09/14/2004 | US6790621 Method of detecting ivermectin sensitivity in a canine subject by identifying a mutation in a mdr1-encoding sequence |
| 09/14/2004 | US6790619 Plant phosphomevalonate kinases |
| 09/14/2004 | US6790613 Method of preparing an oligonucleotide array |
| 09/14/2004 | US6790612 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 09/14/2004 | US6790607 Comprises overexpression of bait hybrid protein containing a dna binding domain (desensitization) or prey hybrid protein containing a dna activation domain for a reporter gene (enhanced sensitivity); uses exogenous activators |
| 09/14/2004 | US6790605 Methods for obtaining a desired bioactivity or biomolecule using DNA libraries from an environmental source |
| 09/14/2004 | US6790449 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins |
| 09/14/2004 | US6790442 Gene expression by immunocompetent cells; antitumor agents, viricides, bactericides, and autoimmuned disease treatment; side effect reduction |
| 09/14/2004 | CA2219629C Transgenic animal models for type ii diabetes mellitus |
| 09/14/2004 | CA2200605C Compositions and methods for the detection of chlamydia trachomatis |
| 09/14/2004 | CA2130115C Prevention of retinal injury and degeneration by specific factors |
| 09/14/2004 | CA2113829C Novel type of gram positive replicon and construction of recombinant vectors containing same |
| 09/14/2004 | CA2088258C Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| 09/14/2004 | CA2073113C Conjugates |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/10/2004 | WO2004077041A1 Analytic chip for quantifying nucleic acid concentration, analytic device for quantifying nucleic acid concentration and analytic method for quantifying nucleic acid concentration |
| 09/10/2004 | WO2004077010A2 Water channel assays |
| 09/10/2004 | WO2004076694A1 Method of detecting chlamydia trachomatis and kit therefor |
| 09/10/2004 | WO2004076689A1 Method of screening compounds which inhibit the initiation of the retrotranscription of the rna of virus hiv-1 and means for implementing same |
| 09/10/2004 | WO2004076675A2 Glutamate transport modulatory compounds and methods |
| 09/10/2004 | WO2004076674A1 Delivery of sirna to cells using polyampholytes |
| 09/10/2004 | WO2004076673A1 Methods and constructs for increasing the content of selected amino acids in seeds |
| 09/10/2004 | WO2004076672A2 Novel dominant selection marker for the transformation of fungi |
| 09/10/2004 | WO2004076671A1 A method for constructing transgenic economic seaweeds |
| 09/10/2004 | WO2004076670A1 Enhanced expression of fusion polypeptides with a biotinylation tag |
| 09/10/2004 | WO2004076669A2 Cysteine-substituted, fad-dependent sulfhydryl oxidases |
| 09/10/2004 | WO2004076668A1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
| 09/10/2004 | WO2004076667A1 Double-strand rna oligonucleotide having effect of inhibiting the expression of cyclin b gene |
| 09/10/2004 | WO2004076666A1 Gasdermin family |
| 09/10/2004 | WO2004076665A2 Vaccines derived from epithelial cell mucin muc-1 |
| 09/10/2004 | WO2004076664A2 Vectors for regulating gene expression |
| 09/10/2004 | WO2004076663A1 INDUCTION OF METHYLATION OF CpG SEQUENCE BY dsRNA IN MAMMALIAN CELL |
| 09/10/2004 | WO2004076661A1 Establishment of disease nerve cells by combining method of highly efficiently inducing nerve differentiation with disease mutation knockin es cells |
| 09/10/2004 | WO2004076660A1 Virus-adsorbing protein and use thereof |
| 09/10/2004 | WO2004076659A2 Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways |